Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
International Urogynecology Journal
Erschienen in: International Urogynecology Journal 8/2012

01.08.2012 | Review Article

A systematic review of clinical studies of electrical stimulation for treatment of lower urinary tract dysfunction

verfasst von: Ash K. Monga, Michael R. Tracey, Jeyakumar Subbaroyan

Erschienen in: International Urogynecology Journal | Ausgabe 8/2012

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

The aim of this manuscript was to provide a systematic literature review of clinical trial evidence for a range of electrical stimulation therapies in the treatment of lower urinary tract symptoms (LUTS).

Methods

The databases MEDLINE, BIOSIS Previews, Inside Conferences, and EMBASE were searched. Original clinical studies with greater than 15 subjects were included.

Results

Seventy-three studies were included, representing implanted sacral nerve stimulation (SNS), percutaneous posterior tibial nerve stimulation (PTNS), and transcutaneous electrical stimulation (TENS) therapy modalities.

Conclusions

Median mean reductions in incontinence episodes and voiding frequency were similar for implanted SNS and PTNS. However, long-term follow-up data to validate the sustained benefit of PTNS are lacking. Despite a substantial body of research devoted to SNS validation, it is not possible to definitively define the appropriate role of this therapy owing largely to study design flaws that inhibited rigorous intention to treat analyses for the majority of these studies.
Literatur
1.
Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S et al (2006) Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 50:1306–1315PubMedCrossRef
2.
Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R et al (2003) Prevalence and burden of overactive bladder in the United States. World J Urol 20:327–336PubMed
3.
Oerlemans DJAJ, van Kerrebroeck PEV (2008) Sacral nerve stimulation for neuromodulation of the lower urinary tract. Neurourol Urodyn 27:28–33PubMedCrossRef
4.
Sherman ND, Amundsen CL (2007) Current and future techniques of neuromodulation for bladder dysfunction. Curr Urol Rep 8:448–454PubMedCrossRef
5.
Abrams P, Blaivas JG, Fowler CJ, Fourcroy JL, Macdiarmid SA, Siegel SW, van Kerrebroeck P (2003) The role of neuromodulation in the management of urinary urge incontinence. BJU Int 91:355–359PubMedCrossRef
6.
7.
Marshall DF, Boston VE (1997) Altered bladder and bowel function following cutaneous electrical field stimulation in children with spina bifida–interim results of a randomized double-blind placebo-controlled trial. Eur J Pediatr Surg 7(Suppl 1):41–43PubMedCrossRef
8.
Bower WF, Moore KH, Adams RD, Shepherd R (1998) A urodynamic study of surface neuromodulation versus sham in detrusor instability and sensory urgency. J Urol 160:2133–2136PubMedCrossRef
9.
Schmidt RA, Jonas U, Oleson KA, Janknegt RA, Hassouna MM, Siegel SW, van Kerrebroeck PE (1999) Sacral nerve stimulation for treatment of refractory urinary urge incontinence. Sacral Nerve Stimulation Study Group. J Urol 162:352–357PubMedCrossRef
10.
Weil EH, Ruiz-Cerdá JL, Eerdmans PH, Janknegt RA, Bemelmans BL, van Kerrebroeck PE (2000) Sacral root neuromodulation in the treatment of refractory urinary urge incontinence: a prospective randomized clinical trial. Eur Urol 37:161–171PubMedCrossRef
11.
Hassouna MM, Siegel SW, Nyeholt AA, Elhilali MM, van Kerrebroeck PE, Das AK et al (2000) Sacral neuromodulation in the treatment of urgency-frequency symptoms: a multicenter study on efficacy and safety. J Urol 163:1849–1854PubMedCrossRef
12.
Svihra J, Kurca E, Luptak J, Kliment J (2002) Neuromodulative treatment of overactive bladder–noninvasive tibial nerve stimulation. Bratisl Lek Listy 103:480–483PubMed
13.
Das AK, Carlson AM, Michael Hull M, U.S. MDT-103 Study Group (2004) Improvement in depression and health-related quality of life after sacral nerve stimulation therapy for treatment of voiding dysfunction. Urology 64:62–68PubMedCrossRef
14.
Guys JM, Haddad M, Planche D, Torre M, Louis-Borrione C, Breaud J (2004) Sacral neuromodulation for neurogenic bladder dysfunction in children. J Urol 172:1673–1676PubMedCrossRef
15.
Hasan ST, Robson WA, Pridie AK, Neal DE (1996) Transcutaneous electrical nerve stimulation and temporary S3 neuromodulation in idiopathic detrusor instability. J Urol 155:2005–2011PubMedCrossRef
16.
Soomro NA, Khadra MH, Robson W, Neal DE (2001) A crossover randomized trial of transcutaneous electrical nerve stimulation and oxybutynin in patients with detrusor instability. J Urol 166:146–149PubMedCrossRef
17.
Scheepens WA, de Bie RA, Weil EHJ, van Kerrebroeck PEV (2002) Unilateral versus bilateral sacral neuromodulation in patients with chronic voiding dysfunction. J Urol 168:2046–2050PubMedCrossRef
18.
Karademir K, Baykal K, Sen B, Senkul T, Iseri C, Erden D (2005) A peripheric neuromodulation technique for curing detrusor overactivity: Stoller afferent neurostimulation. Scand J Urol Nephrol 39:230–233PubMedCrossRef
19.
Finazzi Agrò E, Campagna A, Sciobica F, Petta F, Germani S, Zuccalà A, Miano R (2005) Posterior tibial nerve stimulation: is the once-a-week protocol the best option? Minerva Urol Nefrol 57:119–123PubMed
20.
Barroso U Jr, Lordêlo P, Lopes AA, Andrade J, Macedo A Jr, Ortiz V, Barroso U Jr (2006) Nonpharmacological treatment of lower urinary tract dysfunction using biofeedback and transcutaneous electrical stimulation: a pilot study. BJU Int 98:166–171PubMedCrossRef
21.
Peters KM, MacDiarmid SA, Wooldridge LS, Leong FC, Shobeiri SA, Rovner ES et al (2009) Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial. J Urol 182:1055–1061PubMedCrossRef
22.
McGuire EJ, Zhang SC, Horwinski ER, Lytton B (1983) Treatment of motor and sensory detrusor instability by electrical stimulation. J Urol 129:78–79PubMed
23.
Nakamura M, Sakurai T, Tsujimoto Y, Tada Y (1986) Bladder inhibition by electrical stimulation of the perianal skin. Urol Int 41:62–63PubMedCrossRef
24.
Dijkema HE, Weil EHL, Mijs PT, Janknegt RA (1993) Neuromodulation of sacral nerves for incontinence and voiding dysfunctions. Clinical results and complications. Eur Urol 24:72–76PubMed
25.
Elabbady AA, Hassouna MM, Elhilali MM (1994) Neural stimulation for chronic voiding dysfunctions. J Urol 152:2076–2080PubMed
26.
Koldewijn EL, Rosier PF, Meuleman EJ, Koster AM, Debruyne FM, van Kerrebroeck PE (1994) Predictors of success with neuromodulation in lower urinary tract dysfunction: results of trial stimulation in 100 patients. J Urol 152:2071–2075PubMed
27.
Bosch JL, Groen J (1995) Sacral (S3) segmental nerve stimulation as a treatment for urge incontinence in patients with detrusor instability: results of chronic electrical stimulation using an implantable neural prosthesis. J Urol 154:504–507PubMedCrossRef
28.
Bosch JL, Groen J (1998) Neuromodulation: urodynamic effects of sacral (S3) spinal nerve stimulation in patients with detrusor instability or detrusor hyperreflexia. Behav Brain Res 92:141–150PubMedCrossRef
29.
Shaker HS, Hassouna M (1998) Sacral nerve root neuromodulation: an effective treatment for refractory urge incontinence. J Urol 159:1516–1519PubMedCrossRef
30.
Cappellano F, Ciotti MG, Pizzoccaro M, Catanzaro M, Santambrogio S, Catanzaro F (1998) Sacral root neuromodulation in the treatment of female urge and mixed urinary incontinence. Urogynaecol Int J 12:111–121
31.
Walsh IK, Johnston RS, Keane PF (1999) Transcutaneous sacral neurostimulation for irritative voiding dysfunction. Eur Urol 35:192–196PubMedCrossRef
32.
Bosch JL, Groen J (2000) Sacral nerve neuromodulation in the treatment of patients with refractory motor urge incontinence: long-term results of a prospective longitudinal study. J Urol 163:1219–1222PubMedCrossRef
33.
Klingler HC, Pycha A, Schmidbauer J, Marberger M (2000) Use of peripheral neuromodulation of the S3 region for treatment of detrusor overactivity: a urodynamic-based study. Urology 56:766–771PubMedCrossRef
34.
Siegel SW, Catanzaro F, Dijkema HE, Elhilali MM, Fowler CJ, Gajewski JB et al (2000) Long-term results of a multicenter study on sacral nerve stimulation for treatment of urinary urge incontinence, urgency-frequency, and retention. Urology 56:87–91PubMedCrossRef
35.
Edlund C, Hellström M, Peeker R, Fall M (2000) First Scandinavian experience of electrical sacral nerve stimulation in the treatment of the overactive bladder. Scand J Urol Nephrol 34:366–376PubMedCrossRef
36.
Govier FE, Litwiller S, Nitti V, Kreder KJ, Rosenblatt P (2001) Percutaneous afferent neuromodulation for the refractory overactive bladder: results of a multicenter study. J Urol 165:1193–1196PubMedCrossRef
37.
Janknegt RA, Hassouna MM, Siegel SW, Schmidt RA, Gajewski JB, Rivas DA et al (2001) Long-term effectiveness of sacral nerve stimulation for refractory urge incontinence. Eur Urol 39:101–106PubMedCrossRef
38.
van Balken MR, Vandoninck V, Gisolf KW, Vergunst H, Kiemeney LA, Debruyne FM, Bemelmans BL (2001) Posterior tibial nerve stimulation as neuromodulative treatment of lower urinary tract dysfunction. J Urol 166:914–918PubMedCrossRef
39.
Hoebeke P, Van Laecke E, Everaert K, Renson C, De Paepe H, Raes A, Vande Walle J (2001) Transcutaneous neuromodulation for the urge syndrome in children: a pilot study. J Urol 166:2416–2419PubMedCrossRef
40.
Bower WF, Moore KH, Adams RD (2001) A pilot study of the home application of transcutaneous neuromodulation in children with urgency or urge incontinence. J Urol 166:2420–2422PubMedCrossRef
41.
Hohenfellner M, Humke J, Hampel C, Dahms S, Matzel K, Roth S, Thüroff JW et al (2001) Chronic sacral neuromodulation for treatment of neurogenic bladder dysfunction: long-term results with unilateral implants. Urology 58:887–892PubMedCrossRef
42.
Aboseif S, Tamaddon K, Chalfin S, Freedman S, Kaptein J (2002) Sacral neuromodulation as an effective treatment for refractory pelvic floor dysfunction. Urology 60:52–56PubMedCrossRef
43.
Scheepens WA, Jongen MMGJ, Nieman FHM, de Bie RA, Weil EHJ, van Kerrebroeck PEV (2002) Predictive factors for sacral neuromodulation in chronic lower urinary tract dysfunction. Urology 60:598–602PubMedCrossRef
44.
Amundsen CL, Webster GD (2002) Sacral neuromodulation in an older, urge-incontinent population. Am J Obstet Gynecol 187:1462–1465PubMedCrossRef
45.
Hoebeke P, Renson C, Petillon L, Vande Walle J, De Paepe H (2002) Percutaneous electrical nerve stimulation in children with therapy resistant nonneuropathic bladder sphincter dysfunction: a pilot study. J Urol 168:2605–2607PubMedCrossRef
46.
Scheepens WA, Van Koeveringe GA, De Bie RA, Weil EHJ, Van Kerrebroeck PEV (2002) Long-term efficacy and safety results of the two-stage implantation technique in sacral neuromodulation. BJU Int 90:840–845PubMedCrossRef
47.
Vandoninck V, Van Balken MR, Finazzi Agrò E, Petta F, Caltagirone C, Heesakkers JPFA et al (2003) Posterior tibial nerve stimulation in the treatment of urge incontinence. Neurourol Urodyn 22:17–23PubMedCrossRef
48.
Spinelli M, Giardiello G, Arduini A, van den Hombergh U (2003) New percutaneous technique of sacral nerve stimulation has high initial success rate: preliminary results. Eur Urol 43:70–74PubMedCrossRef
49.
Vandoninck V, van Balken MR, Finazzi Agrò E, Petta F, Micali F, Heesakkers JPFA et al (2003) Posterior tibial nerve stimulation in the treatment of idiopathic nonobstructive voiding dysfunction. Urology 61:567–572PubMedCrossRef
50.
Vandoninck V, van Balken MR, Finazzi Agrò E, Petta F, Micali F, Heesakkers JPFA et al (2003) Percutaneous tibial nerve stimulation in the treatment of overactive bladder: urodynamic data. Neurourol Urodyn 22:227–232PubMedCrossRef
51.
Amarenco G, Ismael SS, Even-Schneider A, Raibaut P, Demaille-Wlodyka S, Parratte B, Kerdraon J (2003) Urodynamic effect of acute transcutaneous posterior tibial nerve stimulation in overactive bladder. J Urol 169:2210–2215PubMedCrossRef
52.
Congregado Ruiz B, Pena Outeiriño XM, Campoy Martínez P, León Dueñas E, Leal López A (2004) Peripheral afferent nerve stimulation for treatment of lower urinary tract irritative symptoms. Eur Urol 45:65–69PubMedCrossRef
53.
Vandoninck V, van Balken MR, Finazzi Agrò E, Heesakkers JPFA, Debruyne FMJ, Kiemeney LALM, Bemelmans BLH (2004) Posterior tibial nerve stimulation in the treatment of voiding dysfunction: urodynamic data. Neurourol Urodyn 23:246–251PubMedCrossRef
54.
De Gennaro M, Capitanucci ML, Mastracci P, Silveri M, Gatti C, Mosiello G (2004) Percutaneous tibial nerve neuromodulation is well tolerated in children and effective for treating refractory vesical dysfunction. J Urol 171:1911–1913PubMedCrossRef
55.
Yokozuka M, Namima T, Nakagawa H, Ichie M, Handa Y (2004) Effects and indications of sacral surface therapeutic electrical stimulation in refractory urinary incontinence. Clin Rehabil 18:899–907PubMedCrossRef
56.
Spinelli M, Weil E, Ostardo E, Del Popolo G, Ruiz-Cerdá JL, Kiss G, Heesakkers J (2005) New tined lead electrode in sacral neuromodulation: experience from a multicentre European study. World J Urol 23:225–229PubMedCrossRef
57.
Kabay SC, Kabay S, Yucel M, Ozden H (2009) Acute urodynamic effects of percutaneous posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with Parkinson’s disease. Neurourol Urodyn 28:62–67PubMedCrossRef
58.
Amundsen CL, Romero AA, Jamison MG, Webster GD (2005) Sacral neuromodulation for intractable urge incontinence: are there factors associated with cure? Urology 66:746–750PubMedCrossRef
59.
Nuhoğlu B, Fidan V, Ayyildiz A, Ersoy E, Germiyanoglu C (2006) Stoller afferent nerve stimulation in woman with therapy resistant over active bladder; a 1-year follow up. Int Urogynecol J Pelvic Floor Dysfunct 17:204–207PubMedCrossRef
60.
Cohen BL, Tunuguntla HSGR, Gousse A (2006) Predictors of success for first stage neuromodulation: motor versus sensory response. J Urol 175:2178–2181PubMedCrossRef
61.
Humphreys MR, Vandersteen DR, Slezak JM, Hollatz P, Smith CA, Smith JE, Reinberg YE (2006) Preliminary results of sacral neuromodulation in 23 children. J Urol 176:2227–2231PubMedCrossRef
62.
Van Voskuilen AC, Oerlemans DJAJ, Weil EHJ, van den Hombergh U, van Kerrebroeck PEVA (2007) Medium-term experience of sacral neuromodulation by tined lead implantation. BJU Int 99:107–110PubMedCrossRef
63.
Foster RT Sr, Anoia EJ, Webster GD, Amundsen CL (2007) In patients undergoing neuromodulation for intractable urge incontinence a reduction in 24-hr pad weight after the initial test stimulation best predicts long-term patient satisfaction. Neurourol Urodyn 26:213–217PubMedCrossRef
64.
Kessler TM, Buchser E, Meyer S, Engeler DS, Al-Khodairy A, Bersch U et al (2007) Sacral neuromodulation for refractory lower urinary tract dysfunction: results of a nationwide registry in Switzerland. Eur Urol 51:1357–1363PubMedCrossRef
65.
van Kerrebroeck PEV, van Voskuilen AC, Heesakkers JPFA, Lycklama á Nijholt AA, Siegel S, Jonas U et al (2007) Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J Urol 178:2029–2034PubMedCrossRef
66.
White WM, Mobley JD III, Doggweiler R, Dobmeyer-Dittrich C, Klein FA (2009) Incidence and predictors of complications with sacral neuromodulation. Urology 73:731–735PubMedCrossRef
67.
MacDiarmid SA, Peters KM, Shobeiri SA, Wooldridge LS, Rovner ES, Leong FC et al (2010) Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder. J Urol 183:234–240PubMedCrossRef
68.
Grünewald V, Höfner K, Thon WF, Kuczyk MA, Jonas U (1999) Sacral electrical neuromodulation as an alternative treatment option for lower urinary tract dysfunction. Restor Neurol Neurosci 14:189–193PubMed
69.
Everaert K, De Ridder D, Baert L, Oosterlinck W, Wyndaele JJ (2000) Patient satisfaction and complications following sacral nerve stimulation for urinary retention, urge incontinence and perineal pain: a multicenter evaluation. Int Urogynecol J Pelvic Floor Dysfunct 11:231–235PubMedCrossRef
70.
Scheepens WA, van Koeveringe GA, de Bie RA, Weil EHJ, van Kerrebroeck PEV (2003) Urodynamic results of sacral neuromodulation correlate with subjective improvement in patients with an overactive bladder. Eur Urol 43:282–287PubMedCrossRef
71.
van Voskuilen AC, Oerlemans DJAJ, Weil EHJ, de Bie RA, van Kerrebroeck PEVA (2006) Long term results of neuromodulation by sacral nerve stimulation for lower urinary tract symptoms: a retrospective single center study. Eur Urol 49:366–372PubMedCrossRef
72.
Groen J, Ruud Bosch JLH, van Mastrigt R (2006) Sacral neuromodulation in women with idiopathic detrusor overactivity incontinence: Decreased overactivity but unchanged bladder contraction strength and urethral resistance during voiding. J Urol 175:1005–1009PubMedCrossRef
73.
Deng DY, Gulati M, Rutman M, Raz S, Rodríguez LV (2006) Failure of sacral nerve stimulation due to migration of tined lead. J Urol 175:2182–2185PubMedCrossRef
74.
Starkman JS, Wolter CE, Scarpero HM, Milam DF, Dmochowski RR (2007) Management of refractory urinary urge incontinence following urogynecological surgery with sacral neuromodulation. Neurourol Urodyn 26:29–35PubMedCrossRef
75.
Sutherland SE, Lavers A, Carlson A, Holtz C, Kesha J, Siegel SW (2007) Sacral nerve stimulation for voiding dysfunction: one institution’s 11-year experience. Neurourol Urodyn 26:19–28PubMedCrossRef
76.
Guralnick ML, Benouni S, O’Connor RC, Edmiston C (2007) Characteristics of infections in patients undergoing staged implantation for sacral nerve stimulation. Urology 69:1073–1076PubMedCrossRef
77.
Datta SN, Chaliha C, Singh A, Gonzales G, Mishra VC, Kavia RBC et al (2008) Sacral neurostimulation for urinary retention: 10-year experience from one UK centre. BJU Int 101:192–196PubMed
78.
Carone R, Bertapelle P, Zanollo A, Spinelli M, Del Popolo G, Lombardi G et al (1999) Sacral neuromodulation in neurogenic lower urinary tract dysfunction: results of a multicenter study group. Urodinamica 9:177–182
79.
Spinelli M, Bertapelle P, Cappellano F, Zanollo A, Carone R, Catanzaro F et al (2001) Chronic sacral neuromodulation in patients with lower urinary tract symptoms: results from a national register. J Urol 166:541–545PubMedCrossRef
80.
Siddiqui NY, Wu JM, Amundsen CL (2010) Efficacy and adverse events of sacral nerve stimulation for overactive bladder: a systematic review. Neurourol Urodyn 29:S18–S23PubMedCrossRef
81.
Kessler TM, La Framboise D, Trelle S, Fowler CJ, Kiss G, Pannek J et al (2010) Sacral neuromodulation for neurogenic lower urinary tract dysfunction: systematic review and meta-analysis. Eur Urol 58:865–874PubMedCrossRef
Metadaten
Titel
A systematic review of clinical studies of electrical stimulation for treatment of lower urinary tract dysfunction
verfasst von
Ash K. Monga
Michael R. Tracey
Jeyakumar Subbaroyan
Publikationsdatum
01.08.2012
Verlag
Springer-Verlag
Erschienen in
International Urogynecology Journal / Ausgabe 8/2012
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-012-1691-5

Weitere Artikel der Ausgabe 8/2012

International Urogynecology Journal 8/2012 Zur Ausgabe

Original Article

Levator function and voluntary augmentation of maximum urethral closure pressure

Letter to the Editor

Differential profile analysis of urinary cytokines in patients with overactive bladder: reply

Editorial

While we wait for a new regulatory framework for surgical mesh

Letter to the Editor

Differential profile analysis of urinary cytokines in patients with overactive bladder: comment

Original Article

Symptoms, quality of life, and factors affecting women’s treatment decisions regarding pelvic organ prolapse

Original Article

Is cervical elongation associated with pelvic organ prolapse?

Neu im Fachgebiet Gynäkologie und Geburtshilfe

23.04.2024 | Medikamente in Schwangerschaft und Stillzeit | Nachrichten

ICI-Therapie in der Schwangerschaft wird gut toleriert

23.04.2024 | Depression antepartal oder postpartal | Nachrichten

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

22.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

20.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika
weitere anzeigen

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen